The objective of this study is to demonstrate the clinical utility of I-124 PET/CT imaging and dosimetry in patients with thyroid cancer including 1) Evaluatio…

Thyroid CancerRAI-Refractory Thyroid Cancer

~Estimated

~$10 – $750

Miami Cancer Research Center, Inc.NCT06443866

Outcomes of Patients With Thyroid Carcinoma Treated With Redifferentiating Agents as Part of Routine Clinical Care: A Prospective Data Collection Study

The purpose of this study to learn more about the use of redifferentiating medications as a standard treatment for radioactive iodine/RAI-refractory thyroid ca…

Thyroid CancerThyroidRefractory Thyroid Cancer

~Estimated

~$10 – $750

Memorial Sloan Kettering Cancer CenterNCT05733013